·
We are excited to share a key milestone for Allegrow Biotech, as we are selected for the Incubio program, the leading biotech incubation program at Hong Kong Science and Technology Park (HKSTP). This marks the moment that we spin out of our alma mater and into the the world class research facilities at the HKSTP's Ma Liu Shui campus, which also provides mentorship and resources for us to scale. We are expecting to graduate the program in 2028, providing us with the foundation and runway to develop and scale our AimGel artificial cell platform to enable researchers and therapy developers worldwide.